Bioteque Corporation
4107
Rank in Stocks
#16152
Established in Taipei, Taiwan, in 1991, Bioteque Corporation operates as a... Established in Taipei, Taiwan, in 1991, Bioteque Corporation operates as a global manufacturer and supplier of medical devices, serving markets across Asia, South America, North America, and other international regions. The company specializes in a diverse range of medical disposables, critical for applications such as hemodialysis access and endovascular treatments. Its comprehensive product line features dialysis equipment, including bloodlines, A.V.F. needles, and hemodialysis catheters; interventional radiology solutions like pigtail drainage catheter sets and introducer sets; and urology essentials such as ureteral stent sets and urine collection bags. Furthermore, Bioteque offers IV administration products, including PVC infusion bags and twist-off ports; respiratory care items like closed suction catheters and endotracheal tubes; and a suite of vascular access products, including angiographic catheters, PTA balloon dilatation catheters, and guidewires. The company also manufactures a wide array of specialized medical components, such as dialyzer connectors, various luer lock connectors, filters, clamps, and transducer protectors, alongside medical masks.
Share Price
$3.25
Last synced: 2026-11-10
Market Cap
$224.98M
Change (1 day)
0.47%
Change (1 year)
-22.00%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Bioteque Corporation (4107)
Category
Healthcare
Operating Margin for Bioteque Corporation (4107)
Operating Margin as of November 2026 TTM: 32.46%
According to Bioteque Corporation's latest financial reports, its current operating margin (TTM) is 32.46%. At the end of 2025 the company had an operating margin of 31.39%.
Operating Margin history for Bioteque Corporation from 2006 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 32.46% | 3.41% |
| 2025 | 31.39% | 1.16% |
| 2024 | 31.03% | 4.02% |
| 2023 | 29.83% | -4.42% |
| 2022 | 31.21% | 5.47% |
| 2021 | 29.59% | -4.46% |
| 2020 | 30.97% | -3.16% |
| 2019 | 31.98% | 5.44% |
| 2018 | 30.33% | 0.60% |
| 2017 | 30.15% | -3.30% |
| 2016 | 31.18% | 6.63% |
| 2015 | 29.24% | 10.13% |
| 2014 | 26.55% | 7.53% |
| 2013 | 24.69% | 34.26% |
| 2012 | 18.39% | 32.11% |
| 2011 | 13.92% | -34.49% |
| 2010 | 21.25% | 6.68% |
| 2009 | 19.92% | 52.88% |
| 2008 | 13.03% | 44.30% |
| 2007 | 9.03% | -11.12% |
| 2006 | 10.16% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 28.37% | -99.13% |
US
|
|
| 12.36% | -99.62% |
FR
|
|
| 9.83% | -99.70% |
US
|
|
| 31.11% | -99.04% |
JP
|
|
| 9.87% | -99.70% |
CH
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Bioteque Corporation's operating margin
What is Bioteque Corporation's operating margin?
Bioteque Corporation's operating margin is 32.46%, as of Nov 2026.
What was Bioteque Corporation's operating margin in 2025?
In 2025, Bioteque Corporation's operating margin was 31.39%, compared with 31.03% in 2024.
How has Bioteque Corporation's operating margin changed since 2020?
From 2020 to 2025, Bioteque Corporation's operating margin was highest in 2025 (31.39%) and lowest in 2021 (29.59%).
How does Bioteque Corporation's operating margin compare with similar companies?
Bioteque Corporation's operating margin (32.46%) is higher than that of all 5 similar companies listed above. The highest among them is HOYA Corporation, with 31.11%.